Chief Financial Officer
Mon, Jun 5, 2023
Jun 5
7,064 shares @ $88.36
Decreased holdings by -6.10%
Net across this filing: 0.00% (+0 shares)
7th largest trade (out of 84)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 42% above 200-day moving average
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology